<DOC>
	<DOC>NCT00235079</DOC>
	<brief_summary>The purpose of the study is to determine whether colchicine is safe and effective in treatment and prevention of recurrent pericarditis after failure of conventional treatment.</brief_summary>
	<brief_title>Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.</brief_title>
	<detailed_description>Colchicine is safe and effective in the management of recurrent pericarditis after failure of conventional treatment. Preliminary data (observational, non-randomized studies without a control group) have shown that the drug may be effective in treatment of the second and subsequent recurrence and the prevention of further recurrences.</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Pericarditis</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>Patients with the second and subsequent attack of recurrent pericarditis, Ageâ‰¥ 18 years, Informed consent. Suspected neoplastic, tuberculous, or purulent etiology, Known severe liver disease and/or elevated transaminases &gt;1.5 times the upper limit of normality, serum creatinine&gt;2.5 mg/dl, Serum CK over the upper limit of normality or Known myopathy, Known gastrointestinal or blood disease, Pregnant or lactating women or women not protected by a contraception method, Known hypersensibility to colchicine, Treatment with colchicine at the enrolment.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Pericarditis</keyword>
	<keyword>Recurrence</keyword>
	<keyword>Therapeutics</keyword>
	<keyword>Prevention</keyword>
	<keyword>Colchicine</keyword>
</DOC>